Share Price and Basic Stock Data
Last Updated: November 19, 2025, 9:35 pm
| PEG Ratio | -3.02 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Jocil Ltd operates in the chemicals sector, specifically focusing on organic chemicals. As of the latest reports, the company’s stock price stood at ₹150, with a market capitalization of ₹134 Cr. Revenue trends indicate a fluctuating performance over the past quarters. Sales reported for the fiscal year ending Mar 2023 were ₹919 Cr, a significant increase from ₹754 Cr in Mar 2022. However, sales for Mar 2024 declined to ₹753 Cr before recovering to ₹866 Cr in Mar 2025. Quarterly sales data reveals variability, with a high of ₹284.41 lakh in Jun 2022, dropping to a low of ₹172.37 lakh in Dec 2023, before rebounding to ₹269.94 lakh in Jun 2025. This inconsistency in sales performance can be attributed to market conditions and operational challenges, reflecting the company’s need to stabilize revenue streams to ensure sustainability.
Profitability and Efficiency Metrics
Jocil Ltd’s profitability metrics reveal challenges, with an operating profit margin (OPM) of just 1.39% as of the latest financial year. The operating profit for Mar 2025 stood at ₹5 Cr, significantly down from ₹18 Cr in Mar 2023. The net profit margin also reflects this trend, reported at only 0.11% for Mar 2025, indicating tight margins that could affect long-term profitability. The company’s return on equity (ROE) was recorded at 0.48%, while the return on capital employed (ROCE) stood at 0.71%, both below typical sector benchmarks. Efficiency measures, such as the cash conversion cycle (CCC), were reported at 54 days, suggesting a relatively slow turnover of working capital. This performance highlights the necessity for improved operational efficiencies to enhance profitability and return metrics.
Balance Sheet Strength and Financial Ratios
The balance sheet of Jocil Ltd shows a conservative approach to debt management, with borrowings reported at ₹5 Cr and a debt-to-equity ratio effectively at zero, indicating minimal leverage. Reserves have increased to ₹201 Cr, providing a cushion for future investments or operational challenges. The interest coverage ratio (ICR) was notably high at 31.18x, reflecting a strong ability to meet interest obligations. However, the price-to-book value (P/BV) ratio stood at 0.59x, suggesting that the market may not fully value the company’s assets relative to its stock price. The current ratio of 2.99x indicates ample liquidity, which is favorable compared to typical industry standards, allowing the company to cover short-term liabilities effectively. Overall, while the balance sheet reflects stability, the low P/BV could indicate market skepticism regarding growth prospects.
Shareholding Pattern and Investor Confidence
The shareholding structure of Jocil Ltd reveals a strong promoter holding of 55.02%, which has remained stable over recent quarters, indicating confidence from the company’s founders in its long-term strategy. Conversely, foreign institutional investors (FIIs) have remained absent, recording 0.00% ownership, which may reflect a lack of interest or perceived risk in the stock. The public shareholding stood at approximately 44.98%, with the number of shareholders reported at 7,446. This relatively stable retail interest suggests a degree of investor confidence, although the declining number of shareholders from 8,736 in Dec 2022 to 7,446 in Sep 2025 raises concerns about the company’s appeal to new investors. Overall, the strong promoter stake provides a level of assurance, but the lack of institutional backing could limit future capital inflows.
Outlook, Risks, and Final Insight
Looking ahead, Jocil Ltd faces both opportunities and risks. The company can leverage its strong balance sheet and high interest coverage to invest in operational improvements and technology upgrades, which could enhance productivity and profitability. However, the volatility in revenue and profitability metrics poses risks, as does the absence of institutional investment, which could hinder growth prospects. Additionally, external factors such as fluctuations in raw material costs and regulatory changes in the chemicals industry could impact operations. For the company to thrive, it must focus on stabilizing revenue, improving operational efficiency, and potentially attracting institutional investors. If successful, these strategies could position Jocil Ltd for a stronger market presence and enhanced shareholder value in the future.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Jocil Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 111 Cr. | 310 | 456/255 | 257 | 392 | 0.03 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,455 Cr. | 9,404 | 14,250/8,150 | 54.0 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 34.4 Cr. | 115 | 329/110 | 17.0 | 26.9 | 0.87 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 315 Cr. | 394 | 428/163 | 17.5 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,659.31 Cr | 1,621.86 | 70.65 | 334.84 | 0.39% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 284.41 | 241.96 | 192.81 | 200.10 | 180.13 | 218.38 | 172.37 | 182.32 | 237.70 | 229.74 | 219.95 | 178.15 | 269.94 |
| Expenses | 279.48 | 238.03 | 188.58 | 195.48 | 177.86 | 215.83 | 175.25 | 179.15 | 234.34 | 227.08 | 222.06 | 176.76 | 266.18 |
| Operating Profit | 4.93 | 3.93 | 4.23 | 4.62 | 2.27 | 2.55 | -2.88 | 3.17 | 3.36 | 2.66 | -2.11 | 1.39 | 3.76 |
| OPM % | 1.73% | 1.62% | 2.19% | 2.31% | 1.26% | 1.17% | -1.67% | 1.74% | 1.41% | 1.16% | -0.96% | 0.78% | 1.39% |
| Other Income | 0.12 | 1.03 | 0.54 | 0.69 | 0.91 | 1.40 | 0.56 | 1.10 | 0.77 | 0.40 | 0.10 | 0.68 | 0.49 |
| Interest | 0.42 | 0.30 | 0.24 | 0.18 | 0.01 | 0.00 | 0.27 | 0.05 | 0.00 | 0.10 | 0.07 | 0.06 | 0.06 |
| Depreciation | 1.57 | 1.52 | 1.55 | 1.56 | 1.38 | 1.48 | 1.63 | 1.62 | 1.39 | 1.42 | 1.43 | 1.42 | 1.22 |
| Profit before tax | 3.06 | 3.14 | 2.98 | 3.57 | 1.79 | 2.47 | -4.22 | 2.60 | 2.74 | 1.54 | -3.51 | 0.59 | 2.97 |
| Tax % | 25.16% | 25.16% | 24.83% | 12.32% | 25.14% | 25.51% | -25.12% | 35.00% | 25.18% | 25.32% | -25.36% | 22.03% | 25.25% |
| Net Profit | 2.29 | 2.35 | 2.23 | 3.13 | 1.34 | 1.85 | -3.16 | 1.69 | 2.05 | 1.15 | -2.63 | 0.45 | 2.22 |
| EPS in Rs | 2.58 | 2.65 | 2.51 | 3.52 | 1.51 | 2.08 | -3.56 | 1.90 | 2.31 | 1.29 | -2.96 | 0.51 | 2.50 |
Last Updated: August 20, 2025, 8:30 am
Below is a detailed analysis of the quarterly data for Jocil Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 269.94 Cr.. The value appears strong and on an upward trend. It has increased from 178.15 Cr. (Mar 2025) to 269.94 Cr., marking an increase of 91.79 Cr..
- For Expenses, as of Jun 2025, the value is 266.18 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 176.76 Cr. (Mar 2025) to 266.18 Cr., marking an increase of 89.42 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.76 Cr.. The value appears strong and on an upward trend. It has increased from 1.39 Cr. (Mar 2025) to 3.76 Cr., marking an increase of 2.37 Cr..
- For OPM %, as of Jun 2025, the value is 1.39%. The value appears strong and on an upward trend. It has increased from 0.78% (Mar 2025) to 1.39%, marking an increase of 0.61%.
- For Other Income, as of Jun 2025, the value is 0.49 Cr.. The value appears to be declining and may need further review. It has decreased from 0.68 Cr. (Mar 2025) to 0.49 Cr., marking a decrease of 0.19 Cr..
- For Interest, as of Jun 2025, the value is 0.06 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.06 Cr..
- For Depreciation, as of Jun 2025, the value is 1.22 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.42 Cr. (Mar 2025) to 1.22 Cr., marking a decrease of 0.20 Cr..
- For Profit before tax, as of Jun 2025, the value is 2.97 Cr.. The value appears strong and on an upward trend. It has increased from 0.59 Cr. (Mar 2025) to 2.97 Cr., marking an increase of 2.38 Cr..
- For Tax %, as of Jun 2025, the value is 25.25%. The value appears to be increasing, which may not be favorable. It has increased from 22.03% (Mar 2025) to 25.25%, marking an increase of 3.22%.
- For Net Profit, as of Jun 2025, the value is 2.22 Cr.. The value appears strong and on an upward trend. It has increased from 0.45 Cr. (Mar 2025) to 2.22 Cr., marking an increase of 1.77 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.50. The value appears strong and on an upward trend. It has increased from 0.51 (Mar 2025) to 2.50, marking an increase of 1.99.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:04 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 375 | 331 | 393 | 376 | 341 | 402 | 446 | 565 | 754 | 919 | 753 | 866 | 914 |
| Expenses | 349 | 305 | 361 | 360 | 331 | 396 | 427 | 544 | 738 | 902 | 748 | 860 | 907 |
| Operating Profit | 26 | 25 | 32 | 16 | 11 | 7 | 19 | 21 | 15 | 18 | 5 | 5 | 7 |
| OPM % | 7% | 8% | 8% | 4% | 3% | 2% | 4% | 4% | 2% | 2% | 1% | 1% | 1% |
| Other Income | 2 | 2 | 5 | 3 | 2 | 2 | 6 | 1 | 1 | 2 | 4 | 2 | 2 |
| Interest | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 10 | 7 | 8 | 7 | 7 | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 5 |
| Profit before tax | 16 | 20 | 27 | 10 | 5 | 1 | 18 | 15 | 10 | 13 | 3 | 1 | 3 |
| Tax % | 30% | 33% | 34% | 19% | 17% | -152% | 29% | 12% | 26% | 22% | 35% | 24% | |
| Net Profit | 11 | 13 | 18 | 8 | 4 | 3 | 12 | 14 | 7 | 10 | 2 | 1 | 2 |
| EPS in Rs | 12.76 | 14.76 | 20.37 | 9.24 | 4.62 | 3.57 | 14.06 | 15.32 | 8.03 | 11.26 | 1.95 | 1.15 | 2.16 |
| Dividend Payout % | 39% | 41% | 34% | 32% | 43% | 28% | 21% | 20% | 25% | 22% | 77% | 44% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 18.18% | 38.46% | -55.56% | -50.00% | -25.00% | 300.00% | 16.67% | -50.00% | 42.86% | -80.00% | -50.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 20.28% | -94.02% | 5.56% | 25.00% | 325.00% | -283.33% | -66.67% | 92.86% | -122.86% | 30.00% |
Jocil Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 5% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -23% |
| 5 Years: | -40% |
| 3 Years: | -48% |
| TTM: | -51% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -3% |
| 3 Years: | -8% |
| 1 Year: | -30% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 3% |
| 3 Years: | 2% |
| Last Year: | 0% |
Last Updated: September 5, 2025, 8:25 am
Balance Sheet
Last Updated: November 9, 2025, 2:19 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 133 | 139 | 150 | 159 | 163 | 165 | 172 | 187 | 195 | 198 | 202 | 197 | 201 |
| Borrowings | 12 | 11 | 9 | 28 | 7 | 8 | 8 | 2 | 4 | 2 | 6 | 0 | 5 |
| Other Liabilities | 89 | 41 | 40 | 54 | 33 | 30 | 51 | 54 | 49 | 46 | 62 | 82 | 74 |
| Total Liabilities | 243 | 200 | 208 | 251 | 212 | 212 | 240 | 252 | 257 | 254 | 279 | 288 | 290 |
| Fixed Assets | 74 | 67 | 63 | 59 | 54 | 50 | 48 | 48 | 47 | 44 | 41 | 37 | 35 |
| CWIP | 0 | 1 | 1 | 2 | 1 | 4 | 5 | 6 | 3 | 0 | 1 | 8 | 9 |
| Investments | 1 | 1 | 1 | 3 | 16 | 9 | 2 | 20 | 9 | 35 | 37 | 30 | 14 |
| Other Assets | 168 | 130 | 143 | 187 | 141 | 150 | 185 | 178 | 198 | 175 | 200 | 212 | 232 |
| Total Assets | 243 | 200 | 208 | 251 | 212 | 212 | 240 | 252 | 257 | 254 | 279 | 288 | 290 |
Below is a detailed analysis of the balance sheet data for Jocil Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
- For Reserves, as of Sep 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 197.00 Cr. (Mar 2025) to 201.00 Cr., marking an increase of 4.00 Cr..
- For Borrowings, as of Sep 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 5.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 74.00 Cr.. The value appears to be improving (decreasing). It has decreased from 82.00 Cr. (Mar 2025) to 74.00 Cr., marking a decrease of 8.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 290.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 288.00 Cr. (Mar 2025) to 290.00 Cr., marking an increase of 2.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Mar 2025) to 35.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 16.00 Cr..
- For Other Assets, as of Sep 2025, the value is 232.00 Cr.. The value appears strong and on an upward trend. It has increased from 212.00 Cr. (Mar 2025) to 232.00 Cr., marking an increase of 20.00 Cr..
- For Total Assets, as of Sep 2025, the value is 290.00 Cr.. The value appears strong and on an upward trend. It has increased from 288.00 Cr. (Mar 2025) to 290.00 Cr., marking an increase of 2.00 Cr..
Notably, the Reserves (201.00 Cr.) exceed the Borrowings (5.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 14.00 | 14.00 | 23.00 | -12.00 | 4.00 | -1.00 | 11.00 | 19.00 | 11.00 | 16.00 | -1.00 | 5.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 53 | 57 | 88 | 53 | 52 | 66 | 55 | 36 | 29 | 32 | 21 |
| Inventory Days | 84 | 89 | 75 | 73 | 81 | 71 | 85 | 66 | 58 | 66 | ||
| Days Payable | 28 | 16 | 21 | 43 | 20 | 15 | 38 | 29 | 29 | 33 | ||
| Cash Conversion Cycle | 100 | 126 | 111 | 119 | 114 | 108 | 114 | 91 | 36 | 29 | 61 | 54 |
| Working Capital Days | 66 | 84 | 88 | 92 | 94 | 89 | 87 | 74 | 69 | 49 | 52 | 45 |
| ROCE % | 11% | 13% | 17% | 7% | 3% | 1% | 10% | 9% | 5% | 7% | 1% | 1% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.15 | 1.94 | 11.25 | 8.02 | 15.32 |
| Diluted EPS (Rs.) | 1.15 | 1.94 | 11.25 | 8.02 | 15.32 |
| Cash EPS (Rs.) | 7.53 | 8.81 | 18.25 | 15.71 | 21.64 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 232.03 | 237.10 | 232.39 | 229.29 | 220.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 232.03 | 237.10 | 232.39 | 229.29 | 220.80 |
| Dividend / Share (Rs.) | 0.50 | 1.50 | 2.50 | 2.00 | 3.00 |
| Revenue From Operations / Share (Rs.) | 974.53 | 848.04 | 1035.04 | 848.48 | 636.56 |
| PBDIT / Share (Rs.) | 8.15 | 10.22 | 22.62 | 18.66 | 24.69 |
| PBIT / Share (Rs.) | 1.77 | 3.35 | 15.63 | 10.98 | 18.37 |
| PBT / Share (Rs.) | 1.51 | 2.98 | 14.35 | 10.78 | 17.37 |
| Net Profit / Share (Rs.) | 1.15 | 1.94 | 11.25 | 8.02 | 15.32 |
| PBDIT Margin (%) | 0.83 | 1.20 | 2.18 | 2.19 | 3.87 |
| PBIT Margin (%) | 0.18 | 0.39 | 1.50 | 1.29 | 2.88 |
| PBT Margin (%) | 0.15 | 0.35 | 1.38 | 1.27 | 2.72 |
| Net Profit Margin (%) | 0.11 | 0.22 | 1.08 | 0.94 | 2.40 |
| Return on Networth / Equity (%) | 0.49 | 0.82 | 4.84 | 3.49 | 6.93 |
| Return on Capital Employeed (%) | 0.75 | 1.39 | 6.60 | 4.69 | 8.12 |
| Return On Assets (%) | 0.35 | 0.61 | 3.94 | 2.77 | 5.39 |
| Total Debt / Equity (X) | 0.00 | 0.02 | 0.01 | 0.02 | 0.01 |
| Asset Turnover Ratio (%) | 3.06 | 2.83 | 3.60 | 2.96 | 2.30 |
| Current Ratio (X) | 2.99 | 3.48 | 4.64 | 3.93 | 3.67 |
| Quick Ratio (X) | 1.35 | 2.02 | 2.74 | 1.76 | 2.16 |
| Inventory Turnover Ratio (X) | 6.20 | 6.80 | 7.74 | 6.93 | 5.72 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 128.54 | 17.77 | 37.38 | 19.57 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 28.35 | 10.96 | 19.10 | 13.86 |
| Earning Retention Ratio (%) | 0.00 | -28.54 | 82.23 | 62.62 | 80.43 |
| Cash Earning Retention Ratio (%) | 0.00 | 71.65 | 89.04 | 80.90 | 86.14 |
| Interest Coverage Ratio (X) | 31.18 | 27.47 | 17.68 | 95.69 | 24.67 |
| Interest Coverage Ratio (Post Tax) (X) | 5.39 | 6.23 | 9.80 | 42.15 | 16.31 |
| Enterprise Value (Cr.) | 97.29 | 129.34 | 129.51 | 172.39 | 121.36 |
| EV / Net Operating Revenue (X) | 0.11 | 0.17 | 0.14 | 0.22 | 0.21 |
| EV / EBITDA (X) | 13.43 | 14.25 | 6.45 | 10.40 | 5.53 |
| MarketCap / Net Operating Revenue (X) | 0.14 | 0.19 | 0.14 | 0.22 | 0.22 |
| Retention Ratios (%) | 0.00 | -28.54 | 82.22 | 62.61 | 80.42 |
| Price / BV (X) | 0.59 | 0.71 | 0.65 | 0.84 | 0.65 |
| Price / Net Operating Revenue (X) | 0.14 | 0.19 | 0.14 | 0.22 | 0.22 |
| EarningsYield | 0.01 | 0.01 | 0.07 | 0.04 | 0.10 |
After reviewing the key financial ratios for Jocil Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 5. It has decreased from 1.94 (Mar 24) to 1.15, marking a decrease of 0.79.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 5. It has decreased from 1.94 (Mar 24) to 1.15, marking a decrease of 0.79.
- For Cash EPS (Rs.), as of Mar 25, the value is 7.53. This value is within the healthy range. It has decreased from 8.81 (Mar 24) to 7.53, marking a decrease of 1.28.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 232.03. It has decreased from 237.10 (Mar 24) to 232.03, marking a decrease of 5.07.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 232.03. It has decreased from 237.10 (Mar 24) to 232.03, marking a decrease of 5.07.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 1.50 (Mar 24) to 0.50, marking a decrease of 1.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 974.53. It has increased from 848.04 (Mar 24) to 974.53, marking an increase of 126.49.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 8.15. This value is within the healthy range. It has decreased from 10.22 (Mar 24) to 8.15, marking a decrease of 2.07.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.77. This value is within the healthy range. It has decreased from 3.35 (Mar 24) to 1.77, marking a decrease of 1.58.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.51. This value is within the healthy range. It has decreased from 2.98 (Mar 24) to 1.51, marking a decrease of 1.47.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.15. This value is below the healthy minimum of 2. It has decreased from 1.94 (Mar 24) to 1.15, marking a decrease of 0.79.
- For PBDIT Margin (%), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 10. It has decreased from 1.20 (Mar 24) to 0.83, marking a decrease of 0.37.
- For PBIT Margin (%), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 10. It has decreased from 0.39 (Mar 24) to 0.18, marking a decrease of 0.21.
- For PBT Margin (%), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 10. It has decreased from 0.35 (Mar 24) to 0.15, marking a decrease of 0.20.
- For Net Profit Margin (%), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.22 (Mar 24) to 0.11, marking a decrease of 0.11.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 15. It has decreased from 0.82 (Mar 24) to 0.49, marking a decrease of 0.33.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 10. It has decreased from 1.39 (Mar 24) to 0.75, marking a decrease of 0.64.
- For Return On Assets (%), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 5. It has decreased from 0.61 (Mar 24) to 0.35, marking a decrease of 0.26.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 3.06. It has increased from 2.83 (Mar 24) to 3.06, marking an increase of 0.23.
- For Current Ratio (X), as of Mar 25, the value is 2.99. This value is within the healthy range. It has decreased from 3.48 (Mar 24) to 2.99, marking a decrease of 0.49.
- For Quick Ratio (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has decreased from 2.02 (Mar 24) to 1.35, marking a decrease of 0.67.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.20. This value is within the healthy range. It has decreased from 6.80 (Mar 24) to 6.20, marking a decrease of 0.60.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 128.54 (Mar 24) to 0.00, marking a decrease of 128.54.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 28.35 (Mar 24) to 0.00, marking a decrease of 28.35.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has increased from -28.54 (Mar 24) to 0.00, marking an increase of 28.54.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 71.65 (Mar 24) to 0.00, marking a decrease of 71.65.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 31.18. This value is within the healthy range. It has increased from 27.47 (Mar 24) to 31.18, marking an increase of 3.71.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.39. This value is within the healthy range. It has decreased from 6.23 (Mar 24) to 5.39, marking a decrease of 0.84.
- For Enterprise Value (Cr.), as of Mar 25, the value is 97.29. It has decreased from 129.34 (Mar 24) to 97.29, marking a decrease of 32.05.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 1. It has decreased from 0.17 (Mar 24) to 0.11, marking a decrease of 0.06.
- For EV / EBITDA (X), as of Mar 25, the value is 13.43. This value is within the healthy range. It has decreased from 14.25 (Mar 24) to 13.43, marking a decrease of 0.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 24) to 0.14, marking a decrease of 0.05.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has increased from -28.54 (Mar 24) to 0.00, marking an increase of 28.54.
- For Price / BV (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has decreased from 0.71 (Mar 24) to 0.59, marking a decrease of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 24) to 0.14, marking a decrease of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Jocil Ltd:
- Net Profit Margin: 0.11%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.75% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.49% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.39
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.35
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 69.7 (Industry average Stock P/E: 70.65)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.11%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Dokiparru Village, Guntur District Andhra Pradesh 522438 | jocil@jocil.net http://www.jocil.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. P Narendranath Chowdary | Chairman |
| Mr. J Murali Mohan | Managing Director |
| Mr. Mullapudi Thimmaraja | Director |
| Mr. K Srinivasa Rao | Director |
| Mr. M Mrutyumjaya Prasad | Director |
| Mr. V S Raju | Independent Director |
| Dr. V N Rao | Independent Director |
| Mrs. Bhargavi Vangala | Independent Director |
| Mr. K Rama Seshayya | Independent Director |
| Mr. P A Chowdary | Independent Director |
| Mr. P Kesavulu Reddy | Independent Director |
| Mr. G S V Prasad | Independent Director |
FAQ
What is the intrinsic value of Jocil Ltd?
Jocil Ltd's intrinsic value (as of 20 November 2025) is 63.37 which is 57.75% lower the current market price of 150.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 133 Cr. market cap, FY2025-2026 high/low of 214/132, reserves of ₹201 Cr, and liabilities of 290 Cr.
What is the Market Cap of Jocil Ltd?
The Market Cap of Jocil Ltd is 133 Cr..
What is the current Stock Price of Jocil Ltd as on 20 November 2025?
The current stock price of Jocil Ltd as on 20 November 2025 is 150.
What is the High / Low of Jocil Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Jocil Ltd stocks is 214/132.
What is the Stock P/E of Jocil Ltd?
The Stock P/E of Jocil Ltd is 69.7.
What is the Book Value of Jocil Ltd?
The Book Value of Jocil Ltd is 236.
What is the Dividend Yield of Jocil Ltd?
The Dividend Yield of Jocil Ltd is 0.33 %.
What is the ROCE of Jocil Ltd?
The ROCE of Jocil Ltd is 0.71 %.
What is the ROE of Jocil Ltd?
The ROE of Jocil Ltd is 0.48 %.
What is the Face Value of Jocil Ltd?
The Face Value of Jocil Ltd is 10.0.